Velocity Vlog: Advances in Merkel Cell Carcinoma - Annual Meeting 2017 Update
In this Velocity Vlog activity, Dr. Howard L. Kaufman of the Rutgers Cancer Institute, provides a brief overview of the incidence and epidemiology of Merkel cell carcinoma and then discusses clinical...
Author: imedex
Added: 07/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - July 11, 2017 Category: Cancer & Oncology Source Type: podcasts
Prof. J ürgen C. Becker, MD, PhD - Progress-in-Practice Master Class—The Coming-of-Age of Immunotherapy in Merkel Cell Carcinoma: Rationale, Evidence, and Practicalities
Progress-in-Practice Master Class—The Coming-of-Age of Immunotherapy in Merkel Cell Carcinoma: Rationale, Evidence, and Practicalities (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - July 5, 2017 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
JAMA Dermatology : Perineural Invasion of Cutaneous Squamous Cell Carcinoma
Interview with Chrysalyne D. Schmults, MD, MSCE, author of Clinical and Incidental Perineural Invasion of Cutaneous Squamous Cell Carcinoma: A Systematic Review and Pooled Analysis of Outcomes Data (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 5, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Lenvatinib in unresectable HCC
Philip Philip, MD of Karmanos Cancer Institute discusses the use of lenvatinib in patients with unresectable hepatocellular carcinoma (HCC) at the 2017 ASCO Annual Meeting in Chicago, IL.
Author: obr
Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts
What tests should a urothelial carcinoma patient get as part of their work up?
Daniel Petrylak, MD of Yale School of Medicine discusses which tests patients with urothelial carcinoma should receive as part of their cancer care at the 2017 ASCO Annual Meeting in Chicago, IL.
Author: obr
Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts
If a urothelial carcinoma patient is progressing on checkpoint inhibitors, whats next for the patient?
Daniel Petrylak, MD of Yale School of Medicine discusses what's next for patient with bladder cancer after checkpoint inhibition therapy at the 2017 ASCO Annual Meeting in Chicago, IL.
Author: obr
Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts
Checkpoint inhibition therapy in urothelial carcinoma cancer
Daniel Petrylak, MD of Yale School of Medicine discusses the role of checkpoint inhibition therapy in urothelial carcinoma cancer at the 2017 ASCO Annual Meeting.
Author: obr
Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts
Is SIRT effective in the treatment of metastatic HCC?
Jeffrey Meyehardt, MD of Harvard Medical School explains whether or not selective internal radiation therapy (SIRT) is effective in treating metastatic hepatocellular carcinoma (HCC) at the 2017 ASCO ...
Author: obr
Added: 06/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2017 Category: Cancer & Oncology Source Type: podcasts
How are checkpoint inhibitors changing the way RCC is treated?
Robert Figlin, MD of Samuel Oschin Comprehensive Cancer Institute explains the use of checkpoint inhibitors is changing the treatment standards for renal cell carcinoma. This was recorded at the 2017 ...
Author: obr
Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts
Sequencing when treating metastatic RCC patients
Robert Figlin, MD of Samuel Oschin Comprehensive Cancer Institute discusses his thoughts on sequencing when treating patients with metastatic renal cell carcinoma. This was recorded at the 2017 ASCO A...
Author: obr
Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts
ASCO 2017: Promising Data on Renal Cell Carcinoma
Robert Figlin, MD of Samuel Oschin Comprehensive Cancer Institute gives an overview of the promising data on renal cell carcinoma presented at the 2017 ASCO Annual Meeting in Chicago, IL.
Author: obr
Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts
Which areas of RCC will impact the treatment landscape in the next 1-3 years?
Robert Figlin, MD of Samuel Oschin Comprehensive Cancer Institute discusses the future impact of new therapies for renal cell carcinoma treatment at the 2017 ASCO Annual Meeting in Chicago, IL.
Author: obr
Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts
Lenvatinib in the 1st line for uHCC treatment
Nevena Damnjanov, MD of Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses the use of lenvatinib in the first line setting for the treatment of hepatocellular carcinoma....
Author: obr
Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts
Differential Expression of c-Met Between Primary and Metastatic Sites in RCC
Aly-Khan Lalani, MD of Dana-Farber Cancer Institute gives an overview of his presentation, Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma (ccR...
Author: ASCO2017
Added: 06/14/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 14, 2017 Category: Cancer & Oncology Source Type: podcasts
Common Questions Asked Regarding c-Met in RCC
Aly-Khan Lalani, MD of Dana-Farber Cancer Institute summarizes the common questions colleagues ask him concerning his study on c-Met expression in renal cell carcinoma. This was recorded at the 2017 A...
Author: ASCO2017
Added: 06/14/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 14, 2017 Category: Cancer & Oncology Source Type: podcasts
